Lymphatic Cancer Survival Rate

There are two types of lymphatic cancer viz., Hodgkin lymphatic cancer and Non-Hodgkin lymphatic cancer. The Hodgkin lymphatic cancer is caused due to the abnormal cells called Reed-Sternberg. The non-Hodgkin lymphatic cancer is a cancer caused without the abnormal cell called Reed-Sternberg. The Hodgkin lymphatic cancer has been found to affect mostly young adults . The incidence rate of males getting the Hodgkin lymphoma is higher than that of the females. According to the research, the Hodgkin lymphoma is common among young people of the age less than 20. In the year 2006, there were 1.1 per 100,000 children, who were affected by the Hodgkin lymphoma. The Hodgkin lymphoma is most common in children, as compared to the non-Hodgkin lymphoma.

Lymphatic Cancer Survival and cure rates

More aggressive forms of non-Hodgkin lymphomas may be fatal, but have a higher likelihood of being cured with chemotherapy. The lower-grade lymphatic cancers have a longer lymphatic survival rate, often 10 or more years, but are often not curable.

Lymphatic Cancer Survival rates by type

Cutaneous anaplastic large cell has the best prognosis, with a 78 percent, five-year survival rate, while peripheral T-cell, anaplastic large T/null cell and angioimmunoblastic lymphoma have a five-year survival rate together of 38 percent to 43 percent. Extranodal NK/T-cell lymphatic cancer and enteropathy-type lymphatic cancer are in the lowest five-year survival rate category, with a prognosis of 22 percent to 24 percent.

Survival rates for non-Hodgkin lymphoma

These factors are important because they allow doctors to plan treatment better than they could if treatment were based only on the type of lymphoma (the pathology report) and staging information.

Each poor prognostic factor is assigned 1 point. People without any poor prognostic factors would have a score of 0, while those with all of the poor prognostic factors would have a score of 5. The index divides people with lymphomas into 4 risk groups:

• Low (0 or 1 poor prognostic factors)
• Low intermediate (2 poor prognostic factors)
• High intermediate (3 poor prognostic factors)
• High (4 or 5 poor prognostic factors)

In the studies used to develop the index, about 75% of people in the lowest risk group lived longer than 5 years, but only about 30% of people in the highest group lived at least 5 years. These numbers show the difference the index scores can make. But newer treatments mean that survival rates are likely to be higher now.

The IPI allows doctors to plan treatment better than they could just based on the type and stage of the lymphoma. This has become more important as new, better treatments have been found that sometimes have more side effects. The index helps doctors figure out whether these treatments are needed. It also gives patients information about the outlook for their future.

Hodgkins disease survival rate

These are the 5-year survival rates.

Stage I: 90% to 95%

Stage II: 90% to 95%

Stage III: 85% to 90%

Stage IV: Around 80%

Since 1960 the Hodgkins disease survival rate has doubled from 40% to over 86% caused by the improvement of the types of treatments.

The cause of Hodgkins disease is unknown. Many studies are trying to change that.
Decadron Diary: A Family’s Journey Through Hodgkin’s Disease
by: Karen Kondor
publisher: Xlibris, Corp., published: 2011-04-20
ASIN: 1462857450
EAN: 9781462857456
sales rank: 3477244
price: $14.10 (new), $45.80 (used)

Based on a collection of emails, Decadron Diary is a combination memoir and self-help book that details one family’s journey through cancer treatment.  At once serious and humorous, Decadron Diary epitomizes the rollercoaster ride that is the daily experience of  anyone facing cancer, whether that person is the patient, the family member, the physician, the nurse, the psychologist or anyone else who crosses paths with cancer.

Hodgkin Lymphoma
publisher: Lippincott Williams & Wilkins, published: 2007-05-18
ASIN: 078176422X
EAN: 9780781764223
sales rank: 1105253
price: $29.47 (new), $29.46 (used)

Recommended Reading

• lymphatic cancer
• Non-Hodgkin – Free Book
• Apocaps CX Apoptogen Formula for Dogs (90 capsules)
• Hodgkin Lymphoma – Enhanced Edition: Learn What Is Cause, Risk Factors, Symptoms, Diagnosis, Treatment and Health Care (Illustrated)
• 21st Century Adult Cancer Sourcebook: Non-Hodgkin Lymphoma (NHL) including Burkitt Lymphoma and Others – Clinical Data for Patients, Families, and Physicians
• Johns Hopkins Patients’ Guide to Lymphoma
• Dying to Have Known
• Diagnostic Pathology: Lymph Nodes and Spleen with Extranodal Lymphomas: Published by Amirsys
• Lymphoma Survivor: Boxing Cat Women’s Cap Sleeve T Health Women’s Cap Sleeve T-Shirt by CafePress
• Lime Green Ribbon Bear w/ Ribbon (12 Teddy Bears)
• Johns Hopkins Patients’ Guide to Lymphoma (Johns Hopkins Medicine)
• lymph nodes